GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Evoke Pharma Inc (STU:EV00) » Definitions » Shiller PE Ratio

Evoke Pharma (STU:EV00) Shiller PE Ratio : (As of May. 16, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Evoke Pharma Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Evoke Pharma Shiller PE Ratio Historical Data

The historical data trend for Evoke Pharma's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Evoke Pharma Shiller PE Ratio Chart

Evoke Pharma Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Evoke Pharma Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Evoke Pharma's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Evoke Pharma's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Evoke Pharma's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Evoke Pharma's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Evoke Pharma's Shiller PE Ratio falls into.



Evoke Pharma Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Evoke Pharma's E10 for the quarter that ended in Dec. 2023 is calculated as:

For example, Evoke Pharma's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-0.541/129.4194*129.4194
=-0.541

Current CPI (Dec. 2023) = 129.4194.

Evoke Pharma Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201403 -4.251 99.695 -5.518
201406 -5.211 100.560 -6.707
201409 -5.867 100.428 -7.561
201412 -4.671 99.070 -6.102
201503 -6.431 99.621 -8.355
201506 -5.560 100.684 -7.147
201509 -4.491 100.392 -5.790
201512 -4.076 99.792 -5.286
201603 -4.849 100.470 -6.246
201606 -4.379 101.688 -5.573
201609 -3.101 101.861 -3.940
201612 -1.365 101.863 -1.734
201703 -4.151 102.862 -5.223
201706 -1.388 103.349 -1.738
201709 -3.423 104.136 -4.254
201712 -0.710 104.011 -0.883
201803 -1.265 105.290 -1.555
201806 -1.438 106.317 -1.750
201809 -0.926 106.507 -1.125
201812 -1.055 105.998 -1.288
201903 -1.168 107.251 -1.409
201906 -0.956 108.070 -1.145
201909 -0.763 108.329 -0.912
201912 -0.648 108.420 -0.774
202003 -0.760 108.902 -0.903
202006 -2.984 108.767 -3.551
202009 -0.815 109.815 -0.960
202012 -0.888 109.897 -1.046
202103 -0.806 111.754 -0.933
202106 -0.706 114.631 -0.797
202109 -0.621 115.734 -0.694
202112 -0.540 117.630 -0.594
202203 -0.726 121.301 -0.775
202206 -0.672 125.017 -0.696
202209 -0.606 125.227 -0.626
202212 -0.500 125.222 -0.517
202303 -0.626 127.348 -0.636
202306 -0.517 128.729 -0.520
202309 -0.478 129.860 -0.476
202312 -0.541 129.419 -0.541

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Evoke Pharma  (STU:EV00) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Evoke Pharma Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Evoke Pharma's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Evoke Pharma (STU:EV00) Business Description

Traded in Other Exchanges
Address
420 Stevens Avenue, Suite 370, Solana Beach, CA, USA, 92075
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.

Evoke Pharma (STU:EV00) Headlines

No Headlines